MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, MIRM made $133,010K in revenue. $2,905K in net income. Net profit margin of 2.18%.

Income Overview

Revenue
$133,010K
Net Income
$2,905K
Net Profit Margin
2.18%
EPS
$0.05
Unit: Thousand (K) dollars
Revenue Breakdown
    • Livmarli
    • Bile Acid Medicines
Revenue Breakdown
    • Livmarli
    • Bile Acid Medicines
Revenue Breakdown
    • US
    • Rest Of World
Revenue Breakdown
    • Research and development expense...
    • Commercialization and medical af...
    • Cost of sales (excluding intangi...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-09-30
Total revenue
133,010 127,785 111,585 90,377
Cost of sales
25,537 23,421 23,018 20,806
Research and development
42,960 46,067 46,044 31,710
Selling, general and administrative
61,910 63,286 57,706 50,545
Total operating expenses
130,407 132,774 126,768 103,061
Income (loss) from operations
2,603 -4,989 -15,183 -12,684
Interest income
3,251 3,033 3,023 3,469
Interest expense
3,606 3,589 3,596 3,586
Other income (expense), net
395 86 2,108 -1,087
Net income (loss) before provision for income taxes
2,643 -5,459 -13,648 -13,888
(benefit from) provision for income taxes
-262 402 1,029 347
Net income (loss)
2,905 -5,861 -14,677 -14,235
Net income (loss) per share, basic (in dollars per share)
0.06 -0.12 -0.3 -0.3
Net income (loss) per share, diluted (in dollars per share)
0.05 -0.12 -0.3 -0.3
Weighted-average shares of common stock outstanding, basic (in shares)
50,639,231 49,726,823 48,889,058 47,782,619
Weighted-average shares of common stock outstanding, diluted (in shares)
56,993,841 49,726,823 48,889,058 47,782,619
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Bile Acid Medicines$40,775K Livmarli$92,235K Product$133,010K Total revenue$133,010K Other income(expense), net$395K Interest income$3,251K Income (loss) fromoperations$2,603K Total operatingexpenses$130,407K (benefit from) provisionfor income taxes-$262K Net income (loss)before provision for...$2,643K Interest expense$3,606K Selling, general andadministrative$61,910K Research and development$42,960K Cost of sales$25,537K Net income (loss)$2,905K

Mirum Pharmaceuticals, Inc. (MIRM)

Mirum Pharmaceuticals, Inc. (MIRM)